Hepatic arterial infusion pump chemotherapy in patients with advanced intrahepatic cholangiocarcinoma confined to the liver: A multicenter phase II trial.
Stijn Franssen(Erasmus MC Cancer Institute), Bas Groot Koerkamp, Adriaan Moelker(Erasmus MC Cancer Institute), Heinz‐Josef Klümpen(Amsterdam University Medical Centers), Lynn E. Nooijen(Amsterdam University Medical Centers), Marjolein Y.V. Homs(Erasmus MC Cancer Institute), Jeroen Hagendoorn(Utrecht University), Nadia Haj Mohammad(Utrecht University), Merve Rousian(Erasmus MC Cancer Institute), B. Ten Haaft(Amsterdam University Medical Centers), Bianca Mostert(Erasmus MC Cancer Institute), Michael Doukas(Erasmus MC), Rutger‐Jan Swijnenburg(Amsterdam University Medical Centers)
Cited by 12
Related Papers
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
|The Lancet Oncology|2016|914
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
|The Lancet. Gastroenterology & hepatology|2019|597
Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic Cholangiocarcinoma
|New England Journal of Medicine|2023|530
Surgery for cholangiocarcinoma
|Liver International|2019|338